Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets.
Beumers L, Vlachavas EI, Borgoni S, Schwarzmuller L, Penso-Dolfin L, Michels BE, Sofyali E, Burmester S, Heiss D, Wilhelm H, Yarden Y, Helm D, Will R, Goncalves A, Wiemann S
NPJ Breast Cancer. 2023 Dec 2;9(1):97. doi: 10.1038/s41523-023-00604-4.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.